Global Anti-VEGF Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Anti-VEGF Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Anti-VEGF Injection industry chain, the market status of Age-related Macular Degeneration (AMD) (Ranibizumab, Bevacizumab), Diabetic Retinopathy (Ranibizumab, Bevacizumab), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Anti-VEGF Injection.
Regionally, the report analyzes the Anti-VEGF Injection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Anti-VEGF Injection market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Anti-VEGF Injection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Anti-VEGF Injection industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Ranibizumab, Bevacizumab).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Anti-VEGF Injection market.
Regional Analysis: The report involves examining the Anti-VEGF Injection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Anti-VEGF Injection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Anti-VEGF Injection:
Company Analysis: Report covers individual Anti-VEGF Injection manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Anti-VEGF Injection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Age-related Macular Degeneration (AMD), Diabetic Retinopathy).
Technology Analysis: Report covers specific technologies relevant to Anti-VEGF Injection. It assesses the current state, advancements, and potential future developments in Anti-VEGF Injection areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Anti-VEGF Injection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Anti-VEGF Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Anti-VEGF Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-VEGF Injection, with price, sales, revenue and global market share of Anti-VEGF Injection from 2019 to 2024.
Chapter 3, the Anti-VEGF Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-VEGF Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Anti-VEGF Injection market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-VEGF Injection.
Chapter 14 and 15, to describe Anti-VEGF Injection sales channel, distributors, customers, research findings and conclusion.
The Global Info Research report includes an overview of the development of the Anti-VEGF Injection industry chain, the market status of Age-related Macular Degeneration (AMD) (Ranibizumab, Bevacizumab), Diabetic Retinopathy (Ranibizumab, Bevacizumab), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Anti-VEGF Injection.
Regionally, the report analyzes the Anti-VEGF Injection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Anti-VEGF Injection market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Anti-VEGF Injection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Anti-VEGF Injection industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Ranibizumab, Bevacizumab).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Anti-VEGF Injection market.
Regional Analysis: The report involves examining the Anti-VEGF Injection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Anti-VEGF Injection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Anti-VEGF Injection:
Company Analysis: Report covers individual Anti-VEGF Injection manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Anti-VEGF Injection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Age-related Macular Degeneration (AMD), Diabetic Retinopathy).
Technology Analysis: Report covers specific technologies relevant to Anti-VEGF Injection. It assesses the current state, advancements, and potential future developments in Anti-VEGF Injection areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Anti-VEGF Injection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Anti-VEGF Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Ranibizumab
- Bevacizumab
- Aflibercept
- Brolucizumab
- Others
- Age-related Macular Degeneration (AMD)
- Diabetic Retinopathy
- Retinal Vein Occlusion (RVO)
- Retinopathy of Prematurity (ROP)
- Uveitis
- Neovascular Glaucoma
- Others
- Roche
- Bayer
- Genentech
- Novartis
- Coherus BioSciences Inc.
- Regeneron
- Qilu Pharmaceutical Co.,Ltd.
- Innovent Biologics
- Anke Biotechnology
- Shenzhen Kangzhe Pharmaceutical Co Ltd
- Chengdu Kanghong Pharmaceutical Group
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Anti-VEGF Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-VEGF Injection, with price, sales, revenue and global market share of Anti-VEGF Injection from 2019 to 2024.
Chapter 3, the Anti-VEGF Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-VEGF Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Anti-VEGF Injection market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-VEGF Injection.
Chapter 14 and 15, to describe Anti-VEGF Injection sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Anti-VEGF Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-VEGF Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Ranibizumab
1.3.3 Bevacizumab
1.3.4 Aflibercept
1.3.5 Brolucizumab
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-VEGF Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Age-related Macular Degeneration (AMD)
1.4.3 Diabetic Retinopathy
1.4.4 Retinal Vein Occlusion (RVO)
1.4.5 Retinopathy of Prematurity (ROP)
1.4.6 Uveitis
1.4.7 Neovascular Glaucoma
1.4.8 Others
1.5 Global Anti-VEGF Injection Market Size & Forecast
1.5.1 Global Anti-VEGF Injection Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Anti-VEGF Injection Sales Quantity (2019-2030)
1.5.3 Global Anti-VEGF Injection Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Anti-VEGF Injection Product and Services
2.1.4 Roche Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments/Updates
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Anti-VEGF Injection Product and Services
2.2.4 Bayer Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bayer Recent Developments/Updates
2.3 Genentech
2.3.1 Genentech Details
2.3.2 Genentech Major Business
2.3.3 Genentech Anti-VEGF Injection Product and Services
2.3.4 Genentech Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Genentech Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Anti-VEGF Injection Product and Services
2.4.4 Novartis Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis Recent Developments/Updates
2.5 Coherus BioSciences Inc.
2.5.1 Coherus BioSciences Inc. Details
2.5.2 Coherus BioSciences Inc. Major Business
2.5.3 Coherus BioSciences Inc. Anti-VEGF Injection Product and Services
2.5.4 Coherus BioSciences Inc. Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Coherus BioSciences Inc. Recent Developments/Updates
2.6 Regeneron
2.6.1 Regeneron Details
2.6.2 Regeneron Major Business
2.6.3 Regeneron Anti-VEGF Injection Product and Services
2.6.4 Regeneron Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Regeneron Recent Developments/Updates
2.7 Qilu Pharmaceutical Co.,Ltd.
2.7.1 Qilu Pharmaceutical Co.,Ltd. Details
2.7.2 Qilu Pharmaceutical Co.,Ltd. Major Business
2.7.3 Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Product and Services
2.7.4 Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
2.8 Innovent Biologics
2.8.1 Innovent Biologics Details
2.8.2 Innovent Biologics Major Business
2.8.3 Innovent Biologics Anti-VEGF Injection Product and Services
2.8.4 Innovent Biologics Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Innovent Biologics Recent Developments/Updates
2.9 Anke Biotechnology
2.9.1 Anke Biotechnology Details
2.9.2 Anke Biotechnology Major Business
2.9.3 Anke Biotechnology Anti-VEGF Injection Product and Services
2.9.4 Anke Biotechnology Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Anke Biotechnology Recent Developments/Updates
2.10 Shenzhen Kangzhe Pharmaceutical Co Ltd
2.10.1 Shenzhen Kangzhe Pharmaceutical Co Ltd Details
2.10.2 Shenzhen Kangzhe Pharmaceutical Co Ltd Major Business
2.10.3 Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Product and Services
2.10.4 Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Shenzhen Kangzhe Pharmaceutical Co Ltd Recent Developments/Updates
2.11 Chengdu Kanghong Pharmaceutical Group
2.11.1 Chengdu Kanghong Pharmaceutical Group Details
2.11.2 Chengdu Kanghong Pharmaceutical Group Major Business
2.11.3 Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Product and Services
2.11.4 Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTI-VEGF INJECTION BY MANUFACTURER
3.1 Global Anti-VEGF Injection Sales Quantity by Manufacturer (2019-2024)
3.2 Global Anti-VEGF Injection Revenue by Manufacturer (2019-2024)
3.3 Global Anti-VEGF Injection Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Anti-VEGF Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Anti-VEGF Injection Manufacturer Market Share in 2023
3.4.2 Top 6 Anti-VEGF Injection Manufacturer Market Share in 2023
3.5 Anti-VEGF Injection Market: Overall Company Footprint Analysis
3.5.1 Anti-VEGF Injection Market: Region Footprint
3.5.2 Anti-VEGF Injection Market: Company Product Type Footprint
3.5.3 Anti-VEGF Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Anti-VEGF Injection Market Size by Region
4.1.1 Global Anti-VEGF Injection Sales Quantity by Region (2019-2030)
4.1.2 Global Anti-VEGF Injection Consumption Value by Region (2019-2030)
4.1.3 Global Anti-VEGF Injection Average Price by Region (2019-2030)
4.2 North America Anti-VEGF Injection Consumption Value (2019-2030)
4.3 Europe Anti-VEGF Injection Consumption Value (2019-2030)
4.4 Asia-Pacific Anti-VEGF Injection Consumption Value (2019-2030)
4.5 South America Anti-VEGF Injection Consumption Value (2019-2030)
4.6 Middle East and Africa Anti-VEGF Injection Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Anti-VEGF Injection Sales Quantity by Type (2019-2030)
5.2 Global Anti-VEGF Injection Consumption Value by Type (2019-2030)
5.3 Global Anti-VEGF Injection Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Anti-VEGF Injection Sales Quantity by Application (2019-2030)
6.2 Global Anti-VEGF Injection Consumption Value by Application (2019-2030)
6.3 Global Anti-VEGF Injection Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Anti-VEGF Injection Sales Quantity by Type (2019-2030)
7.2 North America Anti-VEGF Injection Sales Quantity by Application (2019-2030)
7.3 North America Anti-VEGF Injection Market Size by Country
7.3.1 North America Anti-VEGF Injection Sales Quantity by Country (2019-2030)
7.3.2 North America Anti-VEGF Injection Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Anti-VEGF Injection Sales Quantity by Type (2019-2030)
8.2 Europe Anti-VEGF Injection Sales Quantity by Application (2019-2030)
8.3 Europe Anti-VEGF Injection Market Size by Country
8.3.1 Europe Anti-VEGF Injection Sales Quantity by Country (2019-2030)
8.3.2 Europe Anti-VEGF Injection Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Anti-VEGF Injection Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Anti-VEGF Injection Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Anti-VEGF Injection Market Size by Region
9.3.1 Asia-Pacific Anti-VEGF Injection Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Anti-VEGF Injection Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Anti-VEGF Injection Sales Quantity by Type (2019-2030)
10.2 South America Anti-VEGF Injection Sales Quantity by Application (2019-2030)
10.3 South America Anti-VEGF Injection Market Size by Country
10.3.1 South America Anti-VEGF Injection Sales Quantity by Country (2019-2030)
10.3.2 South America Anti-VEGF Injection Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Anti-VEGF Injection Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Anti-VEGF Injection Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Anti-VEGF Injection Market Size by Country
11.3.1 Middle East & Africa Anti-VEGF Injection Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Anti-VEGF Injection Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Anti-VEGF Injection Market Drivers
12.2 Anti-VEGF Injection Market Restraints
12.3 Anti-VEGF Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Anti-VEGF Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-VEGF Injection
13.3 Anti-VEGF Injection Production Process
13.4 Anti-VEGF Injection Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-VEGF Injection Typical Distributors
14.3 Anti-VEGF Injection Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Anti-VEGF Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-VEGF Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Ranibizumab
1.3.3 Bevacizumab
1.3.4 Aflibercept
1.3.5 Brolucizumab
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-VEGF Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Age-related Macular Degeneration (AMD)
1.4.3 Diabetic Retinopathy
1.4.4 Retinal Vein Occlusion (RVO)
1.4.5 Retinopathy of Prematurity (ROP)
1.4.6 Uveitis
1.4.7 Neovascular Glaucoma
1.4.8 Others
1.5 Global Anti-VEGF Injection Market Size & Forecast
1.5.1 Global Anti-VEGF Injection Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Anti-VEGF Injection Sales Quantity (2019-2030)
1.5.3 Global Anti-VEGF Injection Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Anti-VEGF Injection Product and Services
2.1.4 Roche Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments/Updates
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Anti-VEGF Injection Product and Services
2.2.4 Bayer Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bayer Recent Developments/Updates
2.3 Genentech
2.3.1 Genentech Details
2.3.2 Genentech Major Business
2.3.3 Genentech Anti-VEGF Injection Product and Services
2.3.4 Genentech Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Genentech Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Anti-VEGF Injection Product and Services
2.4.4 Novartis Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis Recent Developments/Updates
2.5 Coherus BioSciences Inc.
2.5.1 Coherus BioSciences Inc. Details
2.5.2 Coherus BioSciences Inc. Major Business
2.5.3 Coherus BioSciences Inc. Anti-VEGF Injection Product and Services
2.5.4 Coherus BioSciences Inc. Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Coherus BioSciences Inc. Recent Developments/Updates
2.6 Regeneron
2.6.1 Regeneron Details
2.6.2 Regeneron Major Business
2.6.3 Regeneron Anti-VEGF Injection Product and Services
2.6.4 Regeneron Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Regeneron Recent Developments/Updates
2.7 Qilu Pharmaceutical Co.,Ltd.
2.7.1 Qilu Pharmaceutical Co.,Ltd. Details
2.7.2 Qilu Pharmaceutical Co.,Ltd. Major Business
2.7.3 Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Product and Services
2.7.4 Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
2.8 Innovent Biologics
2.8.1 Innovent Biologics Details
2.8.2 Innovent Biologics Major Business
2.8.3 Innovent Biologics Anti-VEGF Injection Product and Services
2.8.4 Innovent Biologics Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Innovent Biologics Recent Developments/Updates
2.9 Anke Biotechnology
2.9.1 Anke Biotechnology Details
2.9.2 Anke Biotechnology Major Business
2.9.3 Anke Biotechnology Anti-VEGF Injection Product and Services
2.9.4 Anke Biotechnology Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Anke Biotechnology Recent Developments/Updates
2.10 Shenzhen Kangzhe Pharmaceutical Co Ltd
2.10.1 Shenzhen Kangzhe Pharmaceutical Co Ltd Details
2.10.2 Shenzhen Kangzhe Pharmaceutical Co Ltd Major Business
2.10.3 Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Product and Services
2.10.4 Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Shenzhen Kangzhe Pharmaceutical Co Ltd Recent Developments/Updates
2.11 Chengdu Kanghong Pharmaceutical Group
2.11.1 Chengdu Kanghong Pharmaceutical Group Details
2.11.2 Chengdu Kanghong Pharmaceutical Group Major Business
2.11.3 Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Product and Services
2.11.4 Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTI-VEGF INJECTION BY MANUFACTURER
3.1 Global Anti-VEGF Injection Sales Quantity by Manufacturer (2019-2024)
3.2 Global Anti-VEGF Injection Revenue by Manufacturer (2019-2024)
3.3 Global Anti-VEGF Injection Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Anti-VEGF Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Anti-VEGF Injection Manufacturer Market Share in 2023
3.4.2 Top 6 Anti-VEGF Injection Manufacturer Market Share in 2023
3.5 Anti-VEGF Injection Market: Overall Company Footprint Analysis
3.5.1 Anti-VEGF Injection Market: Region Footprint
3.5.2 Anti-VEGF Injection Market: Company Product Type Footprint
3.5.3 Anti-VEGF Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Anti-VEGF Injection Market Size by Region
4.1.1 Global Anti-VEGF Injection Sales Quantity by Region (2019-2030)
4.1.2 Global Anti-VEGF Injection Consumption Value by Region (2019-2030)
4.1.3 Global Anti-VEGF Injection Average Price by Region (2019-2030)
4.2 North America Anti-VEGF Injection Consumption Value (2019-2030)
4.3 Europe Anti-VEGF Injection Consumption Value (2019-2030)
4.4 Asia-Pacific Anti-VEGF Injection Consumption Value (2019-2030)
4.5 South America Anti-VEGF Injection Consumption Value (2019-2030)
4.6 Middle East and Africa Anti-VEGF Injection Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Anti-VEGF Injection Sales Quantity by Type (2019-2030)
5.2 Global Anti-VEGF Injection Consumption Value by Type (2019-2030)
5.3 Global Anti-VEGF Injection Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Anti-VEGF Injection Sales Quantity by Application (2019-2030)
6.2 Global Anti-VEGF Injection Consumption Value by Application (2019-2030)
6.3 Global Anti-VEGF Injection Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Anti-VEGF Injection Sales Quantity by Type (2019-2030)
7.2 North America Anti-VEGF Injection Sales Quantity by Application (2019-2030)
7.3 North America Anti-VEGF Injection Market Size by Country
7.3.1 North America Anti-VEGF Injection Sales Quantity by Country (2019-2030)
7.3.2 North America Anti-VEGF Injection Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Anti-VEGF Injection Sales Quantity by Type (2019-2030)
8.2 Europe Anti-VEGF Injection Sales Quantity by Application (2019-2030)
8.3 Europe Anti-VEGF Injection Market Size by Country
8.3.1 Europe Anti-VEGF Injection Sales Quantity by Country (2019-2030)
8.3.2 Europe Anti-VEGF Injection Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Anti-VEGF Injection Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Anti-VEGF Injection Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Anti-VEGF Injection Market Size by Region
9.3.1 Asia-Pacific Anti-VEGF Injection Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Anti-VEGF Injection Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Anti-VEGF Injection Sales Quantity by Type (2019-2030)
10.2 South America Anti-VEGF Injection Sales Quantity by Application (2019-2030)
10.3 South America Anti-VEGF Injection Market Size by Country
10.3.1 South America Anti-VEGF Injection Sales Quantity by Country (2019-2030)
10.3.2 South America Anti-VEGF Injection Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Anti-VEGF Injection Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Anti-VEGF Injection Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Anti-VEGF Injection Market Size by Country
11.3.1 Middle East & Africa Anti-VEGF Injection Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Anti-VEGF Injection Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Anti-VEGF Injection Market Drivers
12.2 Anti-VEGF Injection Market Restraints
12.3 Anti-VEGF Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Anti-VEGF Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-VEGF Injection
13.3 Anti-VEGF Injection Production Process
13.4 Anti-VEGF Injection Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-VEGF Injection Typical Distributors
14.3 Anti-VEGF Injection Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Anti-VEGF Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Anti-VEGF Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Anti-VEGF Injection Product and Services
Table 6. Roche Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Roche Recent Developments/Updates
Table 8. Bayer Basic Information, Manufacturing Base and Competitors
Table 9. Bayer Major Business
Table 10. Bayer Anti-VEGF Injection Product and Services
Table 11. Bayer Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Bayer Recent Developments/Updates
Table 13. Genentech Basic Information, Manufacturing Base and Competitors
Table 14. Genentech Major Business
Table 15. Genentech Anti-VEGF Injection Product and Services
Table 16. Genentech Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Genentech Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Anti-VEGF Injection Product and Services
Table 21. Novartis Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Novartis Recent Developments/Updates
Table 23. Coherus BioSciences Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Coherus BioSciences Inc. Major Business
Table 25. Coherus BioSciences Inc. Anti-VEGF Injection Product and Services
Table 26. Coherus BioSciences Inc. Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Coherus BioSciences Inc. Recent Developments/Updates
Table 28. Regeneron Basic Information, Manufacturing Base and Competitors
Table 29. Regeneron Major Business
Table 30. Regeneron Anti-VEGF Injection Product and Services
Table 31. Regeneron Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Regeneron Recent Developments/Updates
Table 33. Qilu Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Qilu Pharmaceutical Co.,Ltd. Major Business
Table 35. Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Product and Services
Table 36. Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 38. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 39. Innovent Biologics Major Business
Table 40. Innovent Biologics Anti-VEGF Injection Product and Services
Table 41. Innovent Biologics Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Innovent Biologics Recent Developments/Updates
Table 43. Anke Biotechnology Basic Information, Manufacturing Base and Competitors
Table 44. Anke Biotechnology Major Business
Table 45. Anke Biotechnology Anti-VEGF Injection Product and Services
Table 46. Anke Biotechnology Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Anke Biotechnology Recent Developments/Updates
Table 48. Shenzhen Kangzhe Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 49. Shenzhen Kangzhe Pharmaceutical Co Ltd Major Business
Table 50. Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Product and Services
Table 51. Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Shenzhen Kangzhe Pharmaceutical Co Ltd Recent Developments/Updates
Table 53. Chengdu Kanghong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 54. Chengdu Kanghong Pharmaceutical Group Major Business
Table 55. Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Product and Services
Table 56. Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
Table 58. Global Anti-VEGF Injection Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 59. Global Anti-VEGF Injection Revenue by Manufacturer (2019-2024) & (USD Million)
Table 60. Global Anti-VEGF Injection Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 61. Market Position of Manufacturers in Anti-VEGF Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 62. Head Office and Anti-VEGF Injection Production Site of Key Manufacturer
Table 63. Anti-VEGF Injection Market: Company Product Type Footprint
Table 64. Anti-VEGF Injection Market: Company Product Application Footprint
Table 65. Anti-VEGF Injection New Market Entrants and Barriers to Market Entry
Table 66. Anti-VEGF Injection Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Anti-VEGF Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 68. Global Anti-VEGF Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 69. Global Anti-VEGF Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 70. Global Anti-VEGF Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 71. Global Anti-VEGF Injection Average Price by Region (2019-2024) & (US$/Unit)
Table 72. Global Anti-VEGF Injection Average Price by Region (2025-2030) & (US$/Unit)
Table 73. Global Anti-VEGF Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 74. Global Anti-VEGF Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 75. Global Anti-VEGF Injection Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Global Anti-VEGF Injection Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Global Anti-VEGF Injection Average Price by Type (2019-2024) & (US$/Unit)
Table 78. Global Anti-VEGF Injection Average Price by Type (2025-2030) & (US$/Unit)
Table 79. Global Anti-VEGF Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 80. Global Anti-VEGF Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 81. Global Anti-VEGF Injection Consumption Value by Application (2019-2024) & (USD Million)
Table 82. Global Anti-VEGF Injection Consumption Value by Application (2025-2030) & (USD Million)
Table 83. Global Anti-VEGF Injection Average Price by Application (2019-2024) & (US$/Unit)
Table 84. Global Anti-VEGF Injection Average Price by Application (2025-2030) & (US$/Unit)
Table 85. North America Anti-VEGF Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 86. North America Anti-VEGF Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 87. North America Anti-VEGF Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 88. North America Anti-VEGF Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 89. North America Anti-VEGF Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 90. North America Anti-VEGF Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 91. North America Anti-VEGF Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 92. North America Anti-VEGF Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Europe Anti-VEGF Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 94. Europe Anti-VEGF Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 95. Europe Anti-VEGF Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 96. Europe Anti-VEGF Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 97. Europe Anti-VEGF Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 98. Europe Anti-VEGF Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 99. Europe Anti-VEGF Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Anti-VEGF Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Anti-VEGF Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 102. Asia-Pacific Anti-VEGF Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 103. Asia-Pacific Anti-VEGF Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 104. Asia-Pacific Anti-VEGF Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 105. Asia-Pacific Anti-VEGF Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 106. Asia-Pacific Anti-VEGF Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 107. Asia-Pacific Anti-VEGF Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 108. Asia-Pacific Anti-VEGF Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 109. South America Anti-VEGF Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 110. South America Anti-VEGF Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 111. South America Anti-VEGF Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 112. South America Anti-VEGF Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 113. South America Anti-VEGF Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 114. South America Anti-VEGF Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 115. South America Anti-VEGF Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 116. South America Anti-VEGF Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 117. Middle East & Africa Anti-VEGF Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 118. Middle East & Africa Anti-VEGF Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 119. Middle East & Africa Anti-VEGF Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 120. Middle East & Africa Anti-VEGF Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 121. Middle East & Africa Anti-VEGF Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 122. Middle East & Africa Anti-VEGF Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 123. Middle East & Africa Anti-VEGF Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 124. Middle East & Africa Anti-VEGF Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 125. Anti-VEGF Injection Raw Material
Table 126. Key Manufacturers of Anti-VEGF Injection Raw Materials
Table 127. Anti-VEGF Injection Typical Distributors
Table 128. Anti-VEGF Injection Typical Customers
LIST OF FIGURE
s
Figure 1. Anti-VEGF Injection Picture
Figure 2. Global Anti-VEGF Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Anti-VEGF Injection Consumption Value Market Share by Type in 2023
Figure 4. Ranibizumab Examples
Figure 5. Bevacizumab Examples
Figure 6. Aflibercept Examples
Figure 7. Brolucizumab Examples
Figure 8. Others Examples
Figure 9. Global Anti-VEGF Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Anti-VEGF Injection Consumption Value Market Share by Application in 2023
Figure 11. Age-related Macular Degeneration (AMD) Examples
Figure 12. Diabetic Retinopathy Examples
Figure 13. Retinal Vein Occlusion (RVO) Examples
Figure 14. Retinopathy of Prematurity (ROP) Examples
Figure 15. Uveitis Examples
Figure 16. Neovascular Glaucoma Examples
Figure 17. Others Examples
Figure 18. Global Anti-VEGF Injection Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 19. Global Anti-VEGF Injection Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 20. Global Anti-VEGF Injection Sales Quantity (2019-2030) & (K Units)
Figure 21. Global Anti-VEGF Injection Average Price (2019-2030) & (US$/Unit)
Figure 22. Global Anti-VEGF Injection Sales Quantity Market Share by Manufacturer in 2023
Figure 23. Global Anti-VEGF Injection Consumption Value Market Share by Manufacturer in 2023
Figure 24. Producer Shipments of Anti-VEGF Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 25. Top 3 Anti-VEGF Injection Manufacturer (Consumption Value) Market Share in 2023
Figure 26. Top 6 Anti-VEGF Injection Manufacturer (Consumption Value) Market Share in 2023
Figure 27. Global Anti-VEGF Injection Sales Quantity Market Share by Region (2019-2030)
Figure 28. Global Anti-VEGF Injection Consumption Value Market Share by Region (2019-2030)
Figure 29. North America Anti-VEGF Injection Consumption Value (2019-2030) & (USD Million)
Figure 30. Europe Anti-VEGF Injection Consumption Value (2019-2030) & (USD Million)
Figure 31. Asia-Pacific Anti-VEGF Injection Consumption Value (2019-2030) & (USD Million)
Figure 32. South America Anti-VEGF Injection Consumption Value (2019-2030) & (USD Million)
Figure 33. Middle East & Africa Anti-VEGF Injection Consumption Value (2019-2030) & (USD Million)
Figure 34. Global Anti-VEGF Injection Sales Quantity Market Share by Type (2019-2030)
Figure 35. Global Anti-VEGF Injection Consumption Value Market Share by Type (2019-2030)
Figure 36. Global Anti-VEGF Injection Average Price by Type (2019-2030) & (US$/Unit)
Figure 37. Global Anti-VEGF Injection Sales Quantity Market Share by Application (2019-2030)
Figure 38. Global Anti-VEGF Injection Consumption Value Market Share by Application (2019-2030)
Figure 39. Global Anti-VEGF Injection Average Price by Application (2019-2030) & (US$/Unit)
Figure 40. North America Anti-VEGF Injection Sales Quantity Market Share by Type (2019-2030)
Figure 41. North America Anti-VEGF Injection Sales Quantity Market Share by Application (2019-2030)
Figure 42. North America Anti-VEGF Injection Sales Quantity Market Share by Country (2019-2030)
Figure 43. North America Anti-VEGF Injection Consumption Value Market Share by Country (2019-2030)
Figure 44. United States Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Canada Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Mexico Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Europe Anti-VEGF Injection Sales Quantity Market Share by Type (2019-2030)
Figure 48. Europe Anti-VEGF Injection Sales Quantity Market Share by Application (2019-2030)
Figure 49. Europe Anti-VEGF Injection Sales Quantity Market Share by Country (2019-2030)
Figure 50. Europe Anti-VEGF Injection Consumption Value Market Share by Country (2019-2030)
Figure 51. Germany Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. France Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. United Kingdom Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Russia Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Italy Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Asia-Pacific Anti-VEGF Injection Sales Quantity Market Share by Type (2019-2030)
Figure 57. Asia-Pacific Anti-VEGF Injection Sales Quantity Market Share by Application (2019-2030)
Figure 58. Asia-Pacific Anti-VEGF Injection Sales Quantity Market Share by Region (2019-2030)
Figure 59. Asia-Pacific Anti-VEGF Injection Consumption Value Market Share by Region (2019-2030)
Figure 60. China Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Japan Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Korea Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. India Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Southeast Asia Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Australia Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. South America Anti-VEGF Injection Sales Quantity Market Share by Type (2019-2030)
Figure 67. South America Anti-VEGF Injection Sales Quantity Market Share by Application (2019-2030)
Figure 68. South America Anti-VEGF Injection Sales Quantity Market Share by Country (2019-2030)
Figure 69. South America Anti-VEGF Injection Consumption Value Market Share by Country (2019-2030)
Figure 70. Brazil Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Argentina Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Middle East & Africa Anti-VEGF Injection Sales Quantity Market Share by Type (2019-2030)
Figure 73. Middle East & Africa Anti-VEGF Injection Sales Quantity Market Share by Application (2019-2030)
Figure 74. Middle East & Africa Anti-VEGF Injection Sales Quantity Market Share by Region (2019-2030)
Figure 75. Middle East & Africa Anti-VEGF Injection Consumption Value Market Share by Region (2019-2030)
Figure 76. Turkey Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Egypt Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Saudi Arabia Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. South Africa Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 80. Anti-VEGF Injection Market Drivers
Figure 81. Anti-VEGF Injection Market Restraints
Figure 82. Anti-VEGF Injection Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of Anti-VEGF Injection in 2023
Figure 85. Manufacturing Process Analysis of Anti-VEGF Injection
Figure 86. Anti-VEGF Injection Industrial Chain
Figure 87. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
Table 1. Global Anti-VEGF Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Anti-VEGF Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Anti-VEGF Injection Product and Services
Table 6. Roche Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Roche Recent Developments/Updates
Table 8. Bayer Basic Information, Manufacturing Base and Competitors
Table 9. Bayer Major Business
Table 10. Bayer Anti-VEGF Injection Product and Services
Table 11. Bayer Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Bayer Recent Developments/Updates
Table 13. Genentech Basic Information, Manufacturing Base and Competitors
Table 14. Genentech Major Business
Table 15. Genentech Anti-VEGF Injection Product and Services
Table 16. Genentech Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Genentech Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Anti-VEGF Injection Product and Services
Table 21. Novartis Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Novartis Recent Developments/Updates
Table 23. Coherus BioSciences Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Coherus BioSciences Inc. Major Business
Table 25. Coherus BioSciences Inc. Anti-VEGF Injection Product and Services
Table 26. Coherus BioSciences Inc. Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Coherus BioSciences Inc. Recent Developments/Updates
Table 28. Regeneron Basic Information, Manufacturing Base and Competitors
Table 29. Regeneron Major Business
Table 30. Regeneron Anti-VEGF Injection Product and Services
Table 31. Regeneron Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Regeneron Recent Developments/Updates
Table 33. Qilu Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Qilu Pharmaceutical Co.,Ltd. Major Business
Table 35. Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Product and Services
Table 36. Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 38. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 39. Innovent Biologics Major Business
Table 40. Innovent Biologics Anti-VEGF Injection Product and Services
Table 41. Innovent Biologics Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Innovent Biologics Recent Developments/Updates
Table 43. Anke Biotechnology Basic Information, Manufacturing Base and Competitors
Table 44. Anke Biotechnology Major Business
Table 45. Anke Biotechnology Anti-VEGF Injection Product and Services
Table 46. Anke Biotechnology Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Anke Biotechnology Recent Developments/Updates
Table 48. Shenzhen Kangzhe Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 49. Shenzhen Kangzhe Pharmaceutical Co Ltd Major Business
Table 50. Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Product and Services
Table 51. Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Shenzhen Kangzhe Pharmaceutical Co Ltd Recent Developments/Updates
Table 53. Chengdu Kanghong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 54. Chengdu Kanghong Pharmaceutical Group Major Business
Table 55. Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Product and Services
Table 56. Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
Table 58. Global Anti-VEGF Injection Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 59. Global Anti-VEGF Injection Revenue by Manufacturer (2019-2024) & (USD Million)
Table 60. Global Anti-VEGF Injection Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 61. Market Position of Manufacturers in Anti-VEGF Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 62. Head Office and Anti-VEGF Injection Production Site of Key Manufacturer
Table 63. Anti-VEGF Injection Market: Company Product Type Footprint
Table 64. Anti-VEGF Injection Market: Company Product Application Footprint
Table 65. Anti-VEGF Injection New Market Entrants and Barriers to Market Entry
Table 66. Anti-VEGF Injection Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Anti-VEGF Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 68. Global Anti-VEGF Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 69. Global Anti-VEGF Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 70. Global Anti-VEGF Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 71. Global Anti-VEGF Injection Average Price by Region (2019-2024) & (US$/Unit)
Table 72. Global Anti-VEGF Injection Average Price by Region (2025-2030) & (US$/Unit)
Table 73. Global Anti-VEGF Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 74. Global Anti-VEGF Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 75. Global Anti-VEGF Injection Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Global Anti-VEGF Injection Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Global Anti-VEGF Injection Average Price by Type (2019-2024) & (US$/Unit)
Table 78. Global Anti-VEGF Injection Average Price by Type (2025-2030) & (US$/Unit)
Table 79. Global Anti-VEGF Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 80. Global Anti-VEGF Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 81. Global Anti-VEGF Injection Consumption Value by Application (2019-2024) & (USD Million)
Table 82. Global Anti-VEGF Injection Consumption Value by Application (2025-2030) & (USD Million)
Table 83. Global Anti-VEGF Injection Average Price by Application (2019-2024) & (US$/Unit)
Table 84. Global Anti-VEGF Injection Average Price by Application (2025-2030) & (US$/Unit)
Table 85. North America Anti-VEGF Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 86. North America Anti-VEGF Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 87. North America Anti-VEGF Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 88. North America Anti-VEGF Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 89. North America Anti-VEGF Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 90. North America Anti-VEGF Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 91. North America Anti-VEGF Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 92. North America Anti-VEGF Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Europe Anti-VEGF Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 94. Europe Anti-VEGF Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 95. Europe Anti-VEGF Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 96. Europe Anti-VEGF Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 97. Europe Anti-VEGF Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 98. Europe Anti-VEGF Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 99. Europe Anti-VEGF Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Anti-VEGF Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Anti-VEGF Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 102. Asia-Pacific Anti-VEGF Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 103. Asia-Pacific Anti-VEGF Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 104. Asia-Pacific Anti-VEGF Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 105. Asia-Pacific Anti-VEGF Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 106. Asia-Pacific Anti-VEGF Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 107. Asia-Pacific Anti-VEGF Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 108. Asia-Pacific Anti-VEGF Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 109. South America Anti-VEGF Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 110. South America Anti-VEGF Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 111. South America Anti-VEGF Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 112. South America Anti-VEGF Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 113. South America Anti-VEGF Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 114. South America Anti-VEGF Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 115. South America Anti-VEGF Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 116. South America Anti-VEGF Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 117. Middle East & Africa Anti-VEGF Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 118. Middle East & Africa Anti-VEGF Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 119. Middle East & Africa Anti-VEGF Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 120. Middle East & Africa Anti-VEGF Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 121. Middle East & Africa Anti-VEGF Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 122. Middle East & Africa Anti-VEGF Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 123. Middle East & Africa Anti-VEGF Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 124. Middle East & Africa Anti-VEGF Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 125. Anti-VEGF Injection Raw Material
Table 126. Key Manufacturers of Anti-VEGF Injection Raw Materials
Table 127. Anti-VEGF Injection Typical Distributors
Table 128. Anti-VEGF Injection Typical Customers
LIST OF FIGURE
s
Figure 1. Anti-VEGF Injection Picture
Figure 2. Global Anti-VEGF Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Anti-VEGF Injection Consumption Value Market Share by Type in 2023
Figure 4. Ranibizumab Examples
Figure 5. Bevacizumab Examples
Figure 6. Aflibercept Examples
Figure 7. Brolucizumab Examples
Figure 8. Others Examples
Figure 9. Global Anti-VEGF Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Anti-VEGF Injection Consumption Value Market Share by Application in 2023
Figure 11. Age-related Macular Degeneration (AMD) Examples
Figure 12. Diabetic Retinopathy Examples
Figure 13. Retinal Vein Occlusion (RVO) Examples
Figure 14. Retinopathy of Prematurity (ROP) Examples
Figure 15. Uveitis Examples
Figure 16. Neovascular Glaucoma Examples
Figure 17. Others Examples
Figure 18. Global Anti-VEGF Injection Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 19. Global Anti-VEGF Injection Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 20. Global Anti-VEGF Injection Sales Quantity (2019-2030) & (K Units)
Figure 21. Global Anti-VEGF Injection Average Price (2019-2030) & (US$/Unit)
Figure 22. Global Anti-VEGF Injection Sales Quantity Market Share by Manufacturer in 2023
Figure 23. Global Anti-VEGF Injection Consumption Value Market Share by Manufacturer in 2023
Figure 24. Producer Shipments of Anti-VEGF Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 25. Top 3 Anti-VEGF Injection Manufacturer (Consumption Value) Market Share in 2023
Figure 26. Top 6 Anti-VEGF Injection Manufacturer (Consumption Value) Market Share in 2023
Figure 27. Global Anti-VEGF Injection Sales Quantity Market Share by Region (2019-2030)
Figure 28. Global Anti-VEGF Injection Consumption Value Market Share by Region (2019-2030)
Figure 29. North America Anti-VEGF Injection Consumption Value (2019-2030) & (USD Million)
Figure 30. Europe Anti-VEGF Injection Consumption Value (2019-2030) & (USD Million)
Figure 31. Asia-Pacific Anti-VEGF Injection Consumption Value (2019-2030) & (USD Million)
Figure 32. South America Anti-VEGF Injection Consumption Value (2019-2030) & (USD Million)
Figure 33. Middle East & Africa Anti-VEGF Injection Consumption Value (2019-2030) & (USD Million)
Figure 34. Global Anti-VEGF Injection Sales Quantity Market Share by Type (2019-2030)
Figure 35. Global Anti-VEGF Injection Consumption Value Market Share by Type (2019-2030)
Figure 36. Global Anti-VEGF Injection Average Price by Type (2019-2030) & (US$/Unit)
Figure 37. Global Anti-VEGF Injection Sales Quantity Market Share by Application (2019-2030)
Figure 38. Global Anti-VEGF Injection Consumption Value Market Share by Application (2019-2030)
Figure 39. Global Anti-VEGF Injection Average Price by Application (2019-2030) & (US$/Unit)
Figure 40. North America Anti-VEGF Injection Sales Quantity Market Share by Type (2019-2030)
Figure 41. North America Anti-VEGF Injection Sales Quantity Market Share by Application (2019-2030)
Figure 42. North America Anti-VEGF Injection Sales Quantity Market Share by Country (2019-2030)
Figure 43. North America Anti-VEGF Injection Consumption Value Market Share by Country (2019-2030)
Figure 44. United States Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Canada Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Mexico Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Europe Anti-VEGF Injection Sales Quantity Market Share by Type (2019-2030)
Figure 48. Europe Anti-VEGF Injection Sales Quantity Market Share by Application (2019-2030)
Figure 49. Europe Anti-VEGF Injection Sales Quantity Market Share by Country (2019-2030)
Figure 50. Europe Anti-VEGF Injection Consumption Value Market Share by Country (2019-2030)
Figure 51. Germany Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. France Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. United Kingdom Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Russia Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Italy Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Asia-Pacific Anti-VEGF Injection Sales Quantity Market Share by Type (2019-2030)
Figure 57. Asia-Pacific Anti-VEGF Injection Sales Quantity Market Share by Application (2019-2030)
Figure 58. Asia-Pacific Anti-VEGF Injection Sales Quantity Market Share by Region (2019-2030)
Figure 59. Asia-Pacific Anti-VEGF Injection Consumption Value Market Share by Region (2019-2030)
Figure 60. China Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Japan Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Korea Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. India Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Southeast Asia Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Australia Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. South America Anti-VEGF Injection Sales Quantity Market Share by Type (2019-2030)
Figure 67. South America Anti-VEGF Injection Sales Quantity Market Share by Application (2019-2030)
Figure 68. South America Anti-VEGF Injection Sales Quantity Market Share by Country (2019-2030)
Figure 69. South America Anti-VEGF Injection Consumption Value Market Share by Country (2019-2030)
Figure 70. Brazil Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Argentina Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Middle East & Africa Anti-VEGF Injection Sales Quantity Market Share by Type (2019-2030)
Figure 73. Middle East & Africa Anti-VEGF Injection Sales Quantity Market Share by Application (2019-2030)
Figure 74. Middle East & Africa Anti-VEGF Injection Sales Quantity Market Share by Region (2019-2030)
Figure 75. Middle East & Africa Anti-VEGF Injection Consumption Value Market Share by Region (2019-2030)
Figure 76. Turkey Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Egypt Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Saudi Arabia Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. South Africa Anti-VEGF Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 80. Anti-VEGF Injection Market Drivers
Figure 81. Anti-VEGF Injection Market Restraints
Figure 82. Anti-VEGF Injection Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of Anti-VEGF Injection in 2023
Figure 85. Manufacturing Process Analysis of Anti-VEGF Injection
Figure 86. Anti-VEGF Injection Industrial Chain
Figure 87. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
